Akin Yilmaz Selected Research

Akin Yilmaz Research Topics

Disease

5	Neoplasms (Cancer) 06/2020 - 08/2005
4	Nephrolithiasis 03/2016 - 02/2009
3	Coronary Artery Disease (Coronary Atherosclerosis) 02/2017 - 01/2007
3	Myocardial Infarction 02/2017 - 01/2009
3	Calcium Oxalate Nephrolithiasis 11/2011 - 02/2009
2	Neoplasm Metastasis (Metastasis) 07/2014 - 04/2011
2	Nonsyndromic Deafness 04/2010 - 04/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2020
1	Breast Neoplasms (Breast Cancer) 04/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2017
1	Kidney Calculi (Kidney Stone) 03/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Hearing Loss (Hearing Impairment) 04/2015
1	Deafness (Deaf Mutism) 04/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2014
1	Postoperative Pain 04/2014
1	Prostatic Neoplasms (Prostate Cancer) 03/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2013
1	Carcinogenesis 07/2013
1	Squamous Cell Carcinoma of Head and Neck 07/2013
1	Multiple Sclerosis 01/2013
1	Neuroinflammatory Diseases 01/2013
1	Colonic Neoplasms (Colon Cancer) 10/2011
1	Inflammation (Inflammations) 07/2011
1	Spermatic Cord Torsion (Testicular Torsion) 07/2011
1	Arthritis (Polyarthritis) 04/2011
1	Tinnitus 01/2010
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 04/2009
1	Obesity 04/2009
1	Urolithiasis 02/2009
1	Coronary Disease (Coronary Heart Disease) 01/2007
1	Necrosis 08/2005

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 04/2017 - 10/2011
4	Messenger RNA (mRNA)IBA 04/2017 - 10/2011
3	DNA (Deoxyribonucleic Acid)IBA 09/2013 - 11/2009
2	EnzymesIBA 06/2020 - 04/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2017 - 01/2016
2	Everolimus FDA Link 04/2017 - 01/2016
2	Calcium OxalateIBA 03/2016 - 02/2009
2	CateninsIBA 07/2014 - 09/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2013 - 07/2011
2	Connexin 26IBA 04/2010 - 04/2008
1	Caspase 2IBA 04/2017
1	Tissue Inhibitor of Metalloproteinase-2IBA 02/2017
1	Calcitriol Receptors (Calcitriol Receptor)IBA 03/2016
1	methyl 4-azidophenylacetimidate (APAI)IBA 03/2016
1	CurcuminIBA 01/2016
1	N- (3- ((2- hydroxynaphthalen- 1- ylmethylene)amino)phenyl)- 2- phenylpropionamideIBA 01/2016
1	benzamideIBA 01/2016
1	TOR Serine-Threonine KinasesIBA 01/2016
1	Histone Deacetylase InhibitorsIBA 01/2016
1	AmidesIBA 01/2016
1	entinostat (MS 275)IBA 01/2016
1	ConnexinsIBA 04/2015
1	trichostatin A (A 300)IBA 07/2014
1	theasinensin AIBA 07/2014
1	Decitabine FDA Link 07/2014
1	Gemcitabine FDA Link 07/2014
1	Secreted Frizzled-Related ProteinsIBA 07/2014
1	Cisplatin (Platino)FDA LinkGeneric 07/2014
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 04/2014
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 03/2014
1	NSC 74859IBA 03/2014
1	MethyltransferasesIBA 09/2013
1	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 07/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2013
1	ChemokinesIBA 01/2013
1	CX3C Chemokine Receptor 1IBA 01/2013
1	Chemokine CX3CL1IBA 01/2013
1	Cadherins (E-Cadherin)IBA 11/2011
1	Fluorouracil (Carac)FDA LinkGeneric 10/2011
1	ApigeninIBA 10/2011
1	RNA (Ribonucleic Acid)IBA 10/2011
1	FlavonoidsIBA 10/2011
1	AntioxidantsIBA 07/2011
1	Carnitine (L-Carnitine)FDA LinkGeneric 07/2011
1	Meloxicam (Mobic)FDA LinkGeneric 07/2011
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2011
1	Matrix Metalloproteinases (MMPs)IBA 04/2011
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2010
1	Serotonin (5 Hydroxytryptamine)IBA 01/2010
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2010
1	Fibronectins (Fibronectin)IBA 11/2009
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 04/2009
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 04/2009
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 04/2009
1	Heparitin Sulfate (Heparan Sulfate)IBA 02/2009
1	beta-2 Adrenergic ReceptorsIBA 01/2009
1	Estrogen ReceptorsIBA 01/2007
1	Estrogens (Estrogen)FDA Link 01/2007
1	triplex DNA (H-DNA)IBA 08/2005
1	Diethylstilbestrol (Stilbestrol)FDA Link 08/2005

Therapy/Procedure

1	Therapeutics 07/2011